{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T02:26:44Z","timestamp":1694744804457},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1097\/mbc.0000000000000745","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T16:26:50Z","timestamp":1529425610000},"page":"501-508","source":"Crossref","is-referenced-by-count":2,"title":["Simvastatin reverses multiple myeloma serum-induced prothrombotic phenotype in endothelial cells via ERK 1\/2 signalling pathway"],"prefix":"10.1097","volume":"29","author":[{"given":"Rujiao","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guibo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuchuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhua","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20210203","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1056\/NEJMc1104560","article-title":"Multiple myeloma","volume":"364","author":"Spitzer","year":"2011","journal-title":"N Engl J Med"},{"key":"R2-4-20210203","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1538-7836.2008.03235.x","article-title":"HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis","volume":"7","author":"Ramcharan","year":"2009","journal-title":"J Thromb Haemost"},{"key":"R3-4-20210203","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1538-7836.2004.00696.x","article-title":"HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women","volume":"2","author":"Doggen","year":"2004","journal-title":"J Thromb Haemost"},{"key":"R4-4-20210203","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1742-1241.2010.02439.x","article-title":"Statin use and the prevention of venous thromboembolism: a meta-analysis","volume":"64","author":"Agarwal","year":"2010","journal-title":"Int J Clin Pract"},{"key":"R5-4-20210203","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMoa0900241","article-title":"A randomized trial of rosuvastatin in the prevention of venous thromboembolism","volume":"360","author":"Glynn","year":"2009","journal-title":"N Engl J Med"},{"key":"R6-4-20210203","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.thromres.2012.12.006","article-title":"Rosuvastatin reduced deep vein thrombosis in ApoE gene deleted mice with hyperlipidemia through nonlipid lowering effects","volume":"131","author":"Patterson","year":"2013","journal-title":"Thromb Res"},{"key":"R7-4-20210203","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11239-012-0687-9","article-title":"Statins, inflammation and deep vein thrombosis: a systematic review","volume":"33","author":"Rodriguez","year":"2012","journal-title":"J Thromb Thrombolysis"},{"key":"R8-4-20210203","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1161\/CIRCULATIONAHA.111.055269","article-title":"Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis","volume":"124","author":"Hackam","year":"2011","journal-title":"Circulation"},{"key":"R9-4-20210203","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1161\/01.STR.0000127786.16612.A4","article-title":"Hypercholesterolemia, HMG-CoA reductase inhibitors, and risk of intracerebral hemorrhage: a case-control study","volume":"35","author":"Woo","year":"2004","journal-title":"Stroke"},{"key":"R10-4-20210203","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-2008-1066020","article-title":"Metabolic modulation of inflammation-induced activation of coagulation","volume":"34","author":"Levi","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"R11-4-20210203","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3324\/haematol.10454","article-title":"Prothrombotic coagulation abnormalities in patients with newly diagnosed multiple myeloma","volume":"92","author":"Auwerda","year":"2007","journal-title":"Haematologica"},{"key":"R12-4-20210203","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1538-7836.2003.00083.x","article-title":"Extremely high levels of von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment","volume":"1","author":"Minnema","year":"2003","journal-title":"J Thromb Haemost"},{"key":"R13-4-20210203","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/01.CIR.0000015465.73933.3B","article-title":"Statin prevents tissue factor expression in human endothelial cells: role of Rho\/Rho-kinase and Akt pathways","volume":"105","author":"Eto","year":"2002","journal-title":"Circulation"},{"key":"R14-4-20210203","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/annrheumdis-2012-201887","article-title":"Simvastatin inhibits the pro-inflammatory and pro-thrombotic effects of IL-17 and TNF-alpha on endothelial cells","volume":"72","author":"Hot","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R15-4-20210203","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0002-9149(96)00742-4","article-title":"The efficacy and six-week tolerability of simvastatin 80 and 160\u200amg\/day","volume":"79","author":"Davidson","year":"1997","journal-title":"Am J Cardiol"},{"key":"R16-4-20210203","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1055\/s-0037-1615646","article-title":"Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation","volume":"85","author":"Berckmans","year":"2001","journal-title":"Thromb Haemost"},{"key":"R17-4-20210203","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1158\/1535-7163.MCT-06-0154","article-title":"Effects of the chemotherapeutic agent doxorubicin on the protein C anticoagulant pathway","volume":"5","author":"Woodley-Cook","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"R18-4-20210203","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/rheumatology\/ken466","article-title":"Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes","volume":"48","author":"Montecucco","year":"2009","journal-title":"Rheumatology (Oxford"},{"key":"R19-4-20210203","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.plipres.2005.05.001","article-title":"Metabolism and functions of phosphatidylserine","volume":"44","author":"Vance","year":"2005","journal-title":"Prog Lipid Res"},{"key":"R20-4-20210203","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1160\/TH10-03-0187","article-title":"Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma","volume":"105","author":"Auwerda","year":"2011","journal-title":"Thromb Haemost"},{"key":"R21-4-20210203","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/ajh.21419","article-title":"A possible link between Trousseau's syndrome and tissue factor producing plasma cells","volume":"84","author":"Shimizu","year":"2009","journal-title":"Am J Hematol"},{"key":"R22-4-20210203","first-page":"1981","article-title":"Phosphatidylserine-exposing cells contribute to the hypercoagulable state in patients with multiple myeloma","volume":"52","author":"Guo","year":"2018","journal-title":"Int J Oncol"},{"key":"R23-4-20210203","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00001721-200204000-00003","article-title":"Activated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications","volume":"13","author":"Zangari","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R24-4-20210203","doi-asserted-by":"crossref","first-page":"26486","DOI":"10.1016\/S0021-9258(18)47220-1","article-title":"Identification, cloning, and regulation of a novel endothelial cell protein C\/activated protein C receptor","volume":"269","author":"Fukudome","year":"1994","journal-title":"J Biol Chem"},{"key":"R25-4-20210203","doi-asserted-by":"crossref","first-page":"10212","DOI":"10.1073\/pnas.93.19.10212","article-title":"The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex","volume":"93","author":"Stearns-Kurosawa","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R26-4-20210203","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.lfs.2017.10.018","article-title":"Puerarin inhibits expression of tissue factor induced by oxidative low-density lipoprotein through activating the PI3K\/Akt\/eNOS pathway and inhibiting activation of ERK1\/2 and NF-kappaB","volume":"191","author":"Deng","year":"2017","journal-title":"Life Sci"},{"key":"R27-4-20210203","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.thromres.2013.11.009","article-title":"Antihuman protein S antibody induces tissue factor expression through a direct interaction with platelet phosphofructokinase","volume":"133","author":"Chen","year":"2014","journal-title":"Thromb Res"},{"key":"R28-4-20210203","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s12272-016-0869-7","article-title":"Suppressive effects of dabrafenib on endothelial protein C receptor shedding","volume":"40","author":"Ku","year":"2017","journal-title":"Arch Pharm Res"},{"key":"R29-4-20210203","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.fitote.2016.03.016","article-title":"Inhibitory effects of three diketopiperazines from marine-derived bacteria on endothelial protein C receptor shedding in human endothelial cells and mice","volume":"110","author":"Lee","year":"2016","journal-title":"Fitoterapia"},{"key":"R30-4-20210203","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1111\/j.1538-7836.2011.04366.x","article-title":"Statins prevent tissue factor induction by protease-activated receptors 1 and 2 in human umbilical vein endothelial cells in vitro","volume":"9","author":"Banfi","year":"2011","journal-title":"J Thromb Haemost"},{"key":"R31-4-20210203","first-page":"1147","article-title":"Atorvastatin induces thrombomodulin expression in the aorta of cholesterol-fed rabbits and in TNFalpha-treated human aortic endothelial cells","volume":"24","author":"Lin","year":"2009","journal-title":"Histol Histopathol"},{"key":"R32-4-20210203","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1074\/jbc.270.8.3849","article-title":"Regulation of the tissue factor promoter in endothelial cells. Binding of NF kappa B-, AP-1-, and Sp1-like transcription factors","volume":"270","author":"Moll","year":"1995","journal-title":"J Biol Chem"},{"key":"R33-4-20210203","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.tiv.2009.08.004","article-title":"Oxidative stress and apoptosis are induced in human endothelial cells exposed to urban particulate matter","volume":"24","author":"Montiel-Davalos","year":"2010","journal-title":"Toxicol In Vitro"},{"key":"R34-4-20210203","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1182\/blood-2009-02-205914","article-title":"Activation of endothelial intrinsic NF-{kappa}B pathway impairs protein C anticoagulation mechanism and promotes coagulation in endotoxemic mice","volume":"114","author":"Song","year":"2009","journal-title":"Blood"},{"key":"R35-4-20210203","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1096\/fj.13-238188","article-title":"Endothelial mineralocorticoid receptor activation enhances endothelial protein C receptor and decreases vascular thrombosis in mice","volume":"28","author":"Lagrange","year":"2014","journal-title":"FASEB J"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00001721-201809000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T12:41:52Z","timestamp":1612874512000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-201809000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0000000000000745","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}